Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
25.2M
-
Shares change
-
+430K
-
Total reported value, excl. options
-
$245M
-
Value change
-
+$4.94M
-
Number of buys
-
38
-
Number of sells
-
-50
-
Price
-
$9.72
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2020
104 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q3 2020.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.2M shares
of 37.4M outstanding shares and own 67.36% of the company stock.
Largest 10 shareholders include Legion Partners Asset Management, LLC (2.9M shares), WYNNEFIELD CAPITAL INC (2.88M shares), Russell Investments Group, Ltd. (2.82M shares), DIMENSIONAL FUND ADVISORS LP (2.3M shares), BlackRock Inc. (1.94M shares), HEARTLAND ADVISORS INC (1.24M shares), INVESTMENT COUNSELORS OF MARYLAND LLC (1.04M shares), Cove Street Capital, LLC (660K shares), Pacific Ridge Capital Partners, LLC (591K shares), and STATE STREET CORP (558K shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.